Skip to main content

Table 1 Clinical demographics of PCa patients

From: Inflammatory metabolic profile of South African patients with prostate cancer

  Treatment-naïve Post-BO
Feature Intermediate, low and very low (n = 14) High
(n = 7)
Very high
(n = 12)
Metastatic
(n = 1)
Total
n = 34)
Non-CRPC
(n = 4)
CRPC
(n = 3)
Total
(n = 7)
Age (year), median [95% CI] 65 [56 77] 70 [52 90] 64 [57 86] 75 [75 75] 68 [63 74] 72 [63 73] 66 [64 70] 70 [65 72]
Ancestry, n (%)         
 Black 1 (7.1) 1 (14.3) 4 (33.3) 1 (100.0) 7 (20.6) 1 (25.0) 1 (33.3) 2 (28.6)
 Colored 10 (71.4) 5 (71.4) 6 (50.0) 0 (0.0) 21 (61.8) 2 (50.0) 1 (33.3) 3 (42.8)
 Colored/Black 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 1 (25.0) 0 (0.0) 1 (14.3)
 White 3 (21.4) 1 (14.3) 2 (16.7) 0 (0.0) 6 (17.6) 0 (0.0) 1 (33.3) 1 (14.3)
PSA (ng/mL), median [95% CI] 9 [3 19] 23 [17 31] 138 [29 3919] >5000 21 [12 84] 4 [2 40] 332 [49 1128] 34 [4 188]
Diabetes, n (%)         
 No 10 (71.4) 5 (71.4) 12 (100.0) 1 (100.0) 28 (82.4) 3 (75.0) 2 (66.7) 5 (71.4)
 Yes 4 (28.6) 2 (28.6) 0 (0.0) 0 (0.0) 6 (17.6) 1 (25.0) 1 (33.3) 2 (28.6)
Hypertension, n (%)         
 No 7 (50.0) 5 (71.4) 10 (83.3) 1 (100.0) 23 (67.6) 3 (75.0) 1 (33.3) 4 (57.1)
 Yes 7 (50.0) 2 (28.6) 2 (16.7) 0 (0.0) 11 (32.4) 1 (25.0) 2 (66.7) 3 (42.9)
Smoker, n (%)         
 No 10 (71.4) 6 (85.7) 9 (75.0) 1 (100.0) 26 (76.5) 4 (100.0) 1 (33.3) 5 (71.4)
 Yes 4 (28.6) 1 (14.3) 3 (25.0) 0 (0.0) 8 (23.5) 0 (0.0) 2 (66.7) 2 (28.6)